InnoMedica’s Strong Core

With its own Nanofactory, InnoMedica has fully control over the development and production of one of the world's most efficient biological nanotransport systems. Known active ingredients are packaged in liposomal nanocarriers produced in-house and equipped with a biological autopilot. Thus, they autonomously find their target in the body via the bloodstream. InnoMedica's nanocarriers are the world's smallest and most durable in the body. Medical therapies are thus delivered gently and optimally to the target area. The protection of the company's proprietary know-how - especially the innovative manufacturing processes - is ensured by a complete value chain under one roof, from the development of the first prototypes to the final filled vial.


InnoMedica's main focus in drug development is on efficient drug logistics in the human body.


A key factor in InnoMedica's innovative strength is the direct link between development and pharmaceutical production.


Thanks to the multi-purpose design of InnoMedica's cleanrooms, they can be flexibly used for the production of different drugs in a modular way.


Statements on Our Work


Most Recent Updates

May 2022

Parkinson trial and internationalization

NEON trial: Dose escalation completed – Parkinson’s patients want to continue treatment with Talineuren. The first …

Read more

March 2022

Stéfan Halbherr and InnoMedica receive CLINAM Award

CLINAM Award 2022 for special achievements in nanomedicine for Stéfan Halbherr and InnoMedica The Scientific Committee of …

Read more

March 2022

Update Talineuren and Capital Increase 2022

First Parkinson’s patients in the NEON study treated with Talineuren On December 14, 2021, the clinical …

Read more